Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

por Yang, Hui, Bueso-Ramos, Carlos, DiNardo, Courtney, Estecio, Marcos R, Davanlou, Masoud, Geng, Qi-Rong, Fang, Zhihong, Nguyen, Martin, Pierce, Sherry, Wei, Yue, Parmar, Simrit, Cortes, Jorge, Kantarjian, Hagop, Garcia-Manero, Guillermo
Publicado 2013